See how to make money instead of spending it on Black Friday with this offer

Ph.D. Economist and Investor Nomi Prins is releasing details on her next stunning prediction…

It involves “liquid energy” that is promising to trigger an energy revolution 117x bigger than all of the hottest tech trends combined. Even the world’s richest billionaires are investing in the tiny company behind it.

And today, you can get in on this cutting-edge financial research at an incredible price tailor-made for Black Friday.

Get Nomi’s latest stock market prediction for $19

ACRS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 6.70%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $4,640,944.49

Aclaris Therapeutics Insider Trading History Chart

Aclaris Therapeutics Share Price & Price History

^$17.53

▼ -0.17 (-0.96%)

As of 11/25/2022 05:00 PM ET

Days: 30 | 90 | 365

THE BEST BLACK FRIDAY DEAL YET

From Legacy Research | Ad

This Black Friday, you can save 95% off of a 1-year membership to Brad Thomas’s Intelligent Income Investor.

This service is geared toward helping you collect the safest dividend income in the market.

It all starts with Brad’s “SWAN” portfolio, of the 10 best companies to own through any market.

Click here now to claim this 95% discount.

Aclaris Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/26/2022	Andrew N Schiff	Director	Sell	14,540	$17.00	$247,180.00	488,381
10/24/2022	Andrew N Schiff	Director	Sell	14,616	$17.01	$248,618.16	514,939
10/17/2022	Andrew N Schiff	Director	Sell	19,944	$16.05	$320,101.20	561,648
10/17/2022	Joseph Monahan	Insider	Sell	5,000	$15.98	$79,900.00	101,386
10/6/2022	Andrew N Schiff	Director	Sell	37,839	$16.54	$625,857.06	588,916
10/4/2022	Andrew N Schiff	Director	Sell	7,700	$16.01	$123,277.00	626,755
6/17/2022	Andrew N. Schiff	Director	Sell	19,565	$15.14	$296,214.10
4/25/2022	Neal Walker	CEO	Sell	20,000	$15.18	$303,600.00	1,245,763
4/21/2022	Neal Walker	CEO	Sell	25,000	$15.24	$381,000.00	1,290,763
4/18/2022	Joseph Monahan	Insider	Sell	30,000	$16.28	$488,400.00	106,386
3/11/2022	Neal Walker	CEO	Sell	56,303	$15.91	$895,780.73
3/10/2022	Frank Ruffo	CFO	Sell	12,823	$15.55	$199,397.65
3/10/2022	Joseph Monahan	Insider	Sell	27,165	$15.71	$426,762.15
2/9/2022	Joseph Monahan	Insider	Sell	383	$12.68	$4,856.44
7/13/2021	David N. Gordon	Insider	Sell	2,631	$16.98	$44,674.38	147,447
6/3/2021	Kamil Ali-Jackson	Insider	Sell	9,492	$21.96	$208,444.32	122,196
6/2/2021	Neal Walker	CEO	Sell	33,260	$21.64	$719,746.40	1,265,442
6/1/2021	David N. Gordon	Insider	Sell	14,000	$23.01	$322,140.00	195,992
5/7/2021	Kamil Ali-Jackson	Insider	Sell	5,416	$23.52	$127,384.32	158,618
5/5/2021	Kamil Ali-Jackson	Insider	Sell	15,000	$23.98	$359,700.00	158,618
5/3/2021	Kamil Ali-Jackson	Insider	Sell	15,000	$24.59	$368,850.00	158,618
4/26/2021	Frank Ruffo	CFO	Sell	27,339	$25.80	$705,346.20	209,059
4/22/2021	Frank Ruffo	CFO	Sell	30,000	$26.84	$805,200.00	209,059

See how to make money instead of spending it on Black Friday with this offer

From Legacy Research | Ad

Get Nomi’s latest stock market prediction for $19

SEC Filings (Institutional Ownership Changes) for Aclaris Therapeutics (NASDAQ:ACRS)

95.08% of Aclaris Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Aclaris Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/22/2022	Teachers Retirement System of The State of Kentucky	54,011	$0.85M	0.0%	N/A	0.081%
11/21/2022	California State Teachers Retirement System	65,616	$1.03M	0.0%	+5.8%	0.098%
11/16/2022	Balyasny Asset Management LLC	106,147	$1.67M	0.0%	N/A	0.159%
11/16/2022	BNP Paribas Arbitrage SNC	21,074	$0.33M	0.0%	+57.8%	0.032%
11/15/2022	State Street Corp	1,303,027	$20.51M	0.0%	+5.9%	1.954%
11/15/2022	Vanguard Group Inc.	2,931,709	$46.15M	0.0%	+4.2%	4.396%
11/15/2022	Price T Rowe Associates Inc. MD	47,106	$0.74M	0.0%	+23.9%	0.071%
11/15/2022	Parkman Healthcare Partners LLC	233,626	$3.68M	1.0%	-23.4%	0.350%
11/15/2022	Laurion Capital Management LP	1,304,624	$20.54M	0.1%	-9.4%	1.957%
11/15/2022	Ensign Peak Advisors Inc	15,950	$0.25M	0.0%	+45.4%	0.024%
11/15/2022	Bank of New York Mellon Corp	233,882	$3.68M	0.0%	+15.7%	0.351%
11/15/2022	BlackRock Inc.	4,810,298	$75.71M	0.0%	+3.0%	7.214%
11/15/2022	Citadel Advisors LLC	1,118,417	$17.60M	0.0%	+17.3%	1.677%
11/14/2022	Point72 Asset Management L.P.	1,853,251	$29.17M	0.1%	+6.9%	2.779%
11/14/2022	Cubist Systematic Strategies LLC	8,109	$0.13M	0.0%	-10.4%	0.012%
11/14/2022	Renaissance Technologies LLC	1,185,178	$18.66M	0.0%	-10.9%	1.777%
11/14/2022	Verition Fund Management LLC	372,507	$5.86M	0.1%	+11.3%	0.559%
11/14/2022	Nuveen Asset Management LLC	221,424	$3.49M	0.0%	-11.7%	0.332%
11/14/2022	AXA S.A.	18,200	$0.29M	0.0%	N/A	0.027%
11/14/2022	Integral Health Asset Management LLC	340,000	$5.35M	1.0%	+18.9%	0.510%
11/10/2022	Credit Suisse AG	41,392	$0.65M	0.0%	+12.0%	0.062%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	26,854	$0.42M	0.0%	N/A	0.040%
11/10/2022	Dimensional Fund Advisors LP	48,017	$0.76M	0.0%	N/A	0.072%
11/10/2022	Tower Research Capital LLC TRC	7,931	$0.13M	0.0%	-39.9%	0.012%
11/9/2022	Amalgamated Bank	10,453	$0.17M	0.0%	+10.6%	0.016%
11/8/2022	Allianz Asset Management GmbH	21,800	$0.34M	0.0%	-78.2%	0.033%
11/8/2022	New York State Common Retirement Fund	46,808	$0.74M	0.0%	+20.5%	0.070%
11/7/2022	Fox Run Management L.L.C.	14,928	$0.24M	0.1%	N/A	0.022%
11/7/2022	Arizona State Retirement System	12,665	$0.20M	0.0%	+9.0%	0.019%
11/7/2022	ProShare Advisors LLC	12,730	$0.20M	0.0%	+6.9%	0.019%
11/3/2022	Barclays PLC	16,707	$0.26M	0.0%	-24.0%	0.025%
11/1/2022	Great West Life Assurance Co. Can	1,944	$31K	0.0%	N/A	0.003%
10/31/2022	SG Americas Securities LLC	13,598	$0.21M	0.0%	N/A	0.020%
10/28/2022	Silverarc Capital Management LLC	543,776	$8.56M	2.9%	+0.8%	0.816%
10/27/2022	Assenagon Asset Management S.A.	194,923	$3.07M	0.0%	-33.5%	0.292%
10/27/2022	Strs Ohio	19,900	$0.31M	0.0%	+11.2%	0.030%
10/26/2022	Allspring Global Investments Holdings LLC	66,136	$1.04M	0.0%	N/A	0.099%
8/30/2022	Verition Fund Management LLC	334,666	$4.67M	0.1%	+31.0%	0.502%
8/22/2022	Legal & General Group Plc	17,689	$0.25M	0.0%	+6.6%	0.027%
8/18/2022	Goldman Sachs Group Inc.	407,889	$5.69M	0.0%	+57.8%	0.612%
8/16/2022	Woodline Partners LP	621,557	$8.68M	0.1%	N/A	0.932%
8/16/2022	Price T Rowe Associates Inc. MD	38,029	$0.53M	0.0%	+20.5%	0.057%
8/16/2022	Commodore Capital LP	2,410,622	$33.65M	7.1%	+4.1%	3.616%
8/15/2022	State Street Corp	1,230,241	$17.17M	0.0%	+13.6%	1.845%
8/15/2022	Acuta Capital Partners LLC	192,835	$2.69M	1.5%	-11.4%	0.289%
8/15/2022	Cubist Systematic Strategies LLC	9,050	$0.13M	0.0%	+163.9%	0.014%
8/15/2022	Point72 Asset Management L.P.	1,733,900	$24.21M	0.1%	-23.9%	2.601%
8/15/2022	Citadel Advisors LLC	953,072	$13.31M	0.0%	-2.0%	1.429%
8/15/2022	Millennium Management LLC	198,794	$2.78M	0.0%	+253.6%	0.298%
8/15/2022	UBS Asset Management Americas Inc.	86,267	$1.20M	0.0%	+74.8%	0.129%
8/13/2022	Renaissance Technologies LLC	1,329,678	$18.56M	0.0%	-8.8%	1.994%
8/13/2022	American International Group Inc.	28,001	$0.39M	0.0%	+10.6%	0.042%
8/12/2022	Northern Trust Corp	523,679	$7.31M	0.0%	+11.4%	0.785%
8/12/2022	Credit Suisse AG	36,942	$0.52M	0.0%	+15.6%	0.055%
8/12/2022	FMR LLC	1,242,308	$17.34M	0.0%	+2.4%	1.863%
8/12/2022	BNP Paribas Arbitrage SA	13,357	$0.19M	0.0%	+201.8%	0.020%
8/12/2022	Rhumbline Advisers	71,999	$1.01M	0.0%	+30.4%	0.108%
8/11/2022	Deutsche Bank AG	1,174,701	$16.40M	0.0%	-19.9%	1.762%
8/11/2022	UBS Group AG	2,406	$34K	0.0%	+41.4%	0.004%
8/11/2022	JPMorgan Chase & Co.	461,596	$6.44M	0.0%	+933.8%	0.692%
8/10/2022	Principal Financial Group Inc.	16,157	$0.23M	0.0%	-49.9%	0.024%
8/9/2022	Swiss National Bank	101,000	$1.41M	0.0%	-6.9%	0.151%
8/5/2022	State Board of Administration of Florida Retirement System	18,504	$0.26M	0.0%	N/A	0.028%
8/3/2022	Integral Health Asset Management LLC	285,971	$3.99M	0.8%	+20.2%	0.430%
8/3/2022	Nisa Investment Advisors LLC	1,828	$26K	0.0%	N/A	0.003%
8/2/2022	Requisite Capital Management LLC	45,000	$0.63M	0.2%	N/A	0.068%
8/1/2022	ProShare Advisors LLC	11,907	$0.17M	0.0%	-25.1%	0.018%
7/28/2022	Arizona State Retirement System	11,615	$0.16M	0.0%	-6.4%	0.017%
7/27/2022	Assenagon Asset Management S.A.	293,045	$4.09M	0.0%	-42.2%	0.440%
7/26/2022	Mirae Asset Global Investments Co. Ltd.	16,245	$0.23M	0.0%	N/A	0.024%
7/25/2022	Silverarc Capital Management LLC	539,545	$7.53M	2.3%	+96.0%	0.810%
7/25/2022	Strs Ohio	17,900	$0.25M	0.0%	N/A	0.027%
6/30/2022	Amalgamated Bank	8,306	$0.14M	0.0%	N/A	0.012%
6/7/2022	Teachers Retirement System of The State of Kentucky	66,814	$1.15M	0.0%	+7.2%	0.100%
6/7/2022	Bank of America Corp DE	31,314	$0.54M	0.0%	-48.4%	0.047%
6/2/2022	Verition Fund Management LLC	255,478	$4.40M	0.1%	+43.3%	0.384%
5/18/2022	BNP Paribas Arbitrage SA	4,426	$76K	0.0%	-59.2%	0.007%
5/17/2022	RA Capital Management L.P.	1,817,808	$31.34M	0.7%	N/A	2.730%
5/17/2022	Royal Bank of Canada	3,137	$54K	0.0%	-70.8%	0.005%
5/17/2022	Rock Springs Capital Management LP	3,865,034	$66.63M	1.7%	+0.1%	5.805%
5/17/2022	Great Point Partners LLC	942,445	$16.25M	3.9%	+17.8%	1.416%
5/16/2022	California State Teachers Retirement System	60,986	$1.05M	0.0%	-8.2%	0.100%
5/16/2022	Goldman Sachs Group Inc.	258,459	$4.46M	0.0%	+16.8%	0.422%
5/16/2022	Wellington Management Group LLP	5,730,253	$98.79M	0.0%	+3.4%	9.352%
5/16/2022	State Street Corp	1,083,390	$18.68M	0.0%	+3.4%	1.768%
5/16/2022	Frazier Life Sciences Management L.P.	408,329	$7.04M	0.6%	N/A	0.666%
5/16/2022	Ghost Tree Capital LLC	125,000	$2.16M	0.5%	-61.5%	0.204%
5/16/2022	UBS Group AG	1,702	$29K	0.0%	-96.3%	0.003%
5/13/2022	Silverarc Capital Management LLC	275,333	$4.75M	2.0%	-3.8%	0.449%
5/13/2022	Renaissance Technologies LLC	1,457,578	$25.13M	0.0%	-13.1%	2.379%
5/13/2022	Northern Trust Corp	470,166	$8.11M	0.0%	-4.0%	0.767%
5/13/2022	Verition Fund Management LLC	255,478	$4.40M	0.1%	+43.3%	0.417%
5/13/2022	Charles Schwab Investment Management Inc.	133,068	$2.30M	0.0%	+3.2%	0.217%
5/13/2022	Affinity Asset Advisors LLC	100,000	$1.72M	0.3%	-75.0%	0.163%
5/13/2022	American International Group Inc.	25,323	$0.44M	0.0%	-6.6%	0.041%
5/13/2022	Parkman Healthcare Partners LLC	668,098	$11.52M	3.4%	-34.9%	1.090%
5/13/2022	Vanguard Group Inc.	2,728,820	$47.05M	0.0%	+0.4%	4.453%
5/13/2022	Allianz Asset Management GmbH	81,965	$1.41M	0.0%	+44.2%	0.134%
5/12/2022	Integral Health Asset Management LLC	238,000	$4.10M	1.1%	+19.0%	0.388%
5/12/2022	BlackRock Inc.	3,987,107	$68.74M	0.0%	-2.2%	6.507%

Data available starting January 2016

Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of laboratory services. The company also develops Zunsemetinib, an MK2 inhibitor for the treatment of moderate to severe rheumatoid and Psoriatic arthritis, and Hidradenitis suppurativa; and ATI-1777, a soft JAK 1/3 inhibitor for the treatment of moderate to severe atopic dermatitis. In addition, it develops ATI-2138, an ITK/TXK/JAK3 inhibitor as a potential treatment for T cell-mediated autoimmune diseases; Gut-Biased Program for inflammatory bowel disease; and ATI-2231, an MK2 inhibitor treatment for pancreatic and metastatic breast cancer. The company was incorporated in 2012 and is headquartered in Wayne, Pennsylvania.

Today's Range

Now: $17.53

$17.53

$17.83

50 Day Range

MA: $15.98

$13.07

$18.37

52 Week Range

Now: $17.53

$9.26

$18.96

Volume

65,539 shs

Average Volume

412,158 shs

Market Capitalization

$1.17 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.55

Who are the company insiders with the largest holdings of Aclaris Therapeutics?: Aclaris Therapeutics' top insider shareholders include:
Neal Walker (CEO)
Andrew N Schiff (Director)
Frank Ruffo (CFO)
David N Gordon (Insider)
Kamil Ali-Jackson (Insider)
Joseph Monahan (Insider)
Andrew N Schiff (Director)
Learn More about top insider investors at Aclaris Therapeutics.
Who are the major institutional investors of Aclaris Therapeutics?: Aclaris Therapeutics' top institutional investors include:
BlackRock Inc. — 7.21%
Vanguard Group Inc. — 4.40%
Point72 Asset Management L.P. — 2.78%
Laurion Capital Management LP — 1.96%
State Street Corp — 1.95%
Renaissance Technologies LLC — 1.78%
Learn More about top institutional investors of Aclaris Therapeutics stock.
Which major investors are selling Aclaris Therapeutics stock?: Within the last quarter, ACRS stock was sold by these institutional investors:
Renaissance Technologies LLC
Laurion Capital Management LP
Assenagon Asset Management S.A.
Allianz Asset Management GmbH
Parkman Healthcare Partners LLC
Nuveen Asset Management LLC
Tower Research Capital LLC TRC
Barclays PLC
Within the previous year, company insiders that have sold Aclaris Therapeutics company stock include:
Neal Walker (CEO)
Andrew N Schiff (Director)
Frank Ruffo (CFO)
David N Gordon (Insider)
Kamil Ali-Jackson (Insider)
Learn More investors selling Aclaris Therapeutics stock.
Which major investors are buying Aclaris Therapeutics stock?: During the previous quarter, ACRS stock was acquired by institutional investors including:
Citadel Advisors LLC
BlackRock Inc.
Point72 Asset Management L.P.
Vanguard Group Inc.
Balyasny Asset Management LLC
State Street Corp
Allspring Global Investments Holdings LLC
Integral Health Asset Management LLC

See how to make money instead of spending it on Black Friday with this offer

From Legacy Research | Ad

Get Nomi’s latest stock market prediction for $19

ACRS Insider Trading

Aclaris Therapeutics Insider Trading History Chart

Aclaris Therapeutics Share Price & Price History

Aclaris Therapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for Aclaris Therapeutics (NASDAQ:ACRS)

Institutional Buying and Selling by Quarter

Aclaris Therapeutics Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Aclaris Therapeutics?

Who are the major institutional investors of Aclaris Therapeutics?

Which major investors are selling Aclaris Therapeutics stock?

Which major investors are buying Aclaris Therapeutics stock?